OnKure Therapeutics (OKUR) director corrects Form 4 on 15,300-share stock option
Rhea-AI Filing Summary
OnKure Therapeutics, Inc. director Isaac Manke filed an amended ownership report reflecting a stock option holding rather than a transaction. The amendment states that a previously reported disposition and corresponding acquisition of an option to purchase 15,300 shares of Class A Common Stock in connection with an Option Repricing did not occur. The filing instead reports a stock option, exercisable at $18.20 per share, covering 15,300 underlying shares and expiring on October 3, 2034. According to the vesting schedule, 1/36 of the option vested on November 4, 2024 and 1/36 continues to vest monthly, contingent on continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Manke Isaac
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (right to buy) F1, F2 | -- | -- | -- |
Holdings After Transaction:
Stock Option (right to buy) — 15,300 shares (Direct)
Footnotes (2)
- F1. The original Form 4, filed August 11, 2026, reported the disposition on August 7, 2026 of an option to purchase 15,300 shares of Class A Common Stock (the "Disposition"), and a corresponding acquisition of an option to purchase 15,300 shares of Class A Common Stock (the "Acquisition"), each in connection with an Option Repricing, as defined in footnote 3 of the original Form 4. The Disposition and Acquisition did not occur.
- F2. 1/36th of the shares subject to the option vested on November 4, 2024 and 1/36th of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
Key Figures
Underlying shares: 15,300 shares
Exercise price: $18.20 per share
Option expiration: October 3, 2034
+1 more
4 metrics
Underlying shares
15,300 shares
Shares of Class A Common Stock subject to the reported stock option holding
Exercise price
$18.20 per share
Exercise price of the stock option reported as a holding
Option expiration
October 3, 2034
Expiration date of the stock option on Class A Common Stock
Vesting start date
November 4, 2024
Date when 1/36 of the shares subject to the option initially vested
Key Terms
Option Repricing, Class A Common Stock, vesting
3 terms
Option Repricing financial
"each in connection with an Option Repricing, as defined in footnote 3"
Class A Common Stock financial
"option to purchase 15,300 shares of Class A Common Stock"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
vesting financial
"1/36th of the shares subject to the option vested on November 4, 2024"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
What does the Form 4/A filed for OKUR by Isaac Manke change?
The amendment clarifies that a previously reported disposition and acquisition of an option to purchase 15,300 shares of Class A Common Stock in connection with an Option Repricing did not occur. Instead, it reflects a continuing stock option holding with defined exercise and vesting terms.
What is the exercise price and expiration date of Isaac Manke’s OKUR stock option?
The option has an exercise price of $18.20 per share and an expiration date of October 3, 2034. These terms define the cost to purchase each underlying share and the final date by which the option may be exercised, assuming vesting and service conditions are met.
How does Isaac Manke’s OKUR option vest according to the amended filing?
The filing states that 1/36 of the shares subject to the option vested on November 4, 2024, with an additional 1/36 vesting each month thereafter. Vesting continues only while the reporting person remains a service provider through each applicable vesting date.
Was Isaac Manke’s OKUR Form 4/A filed under a Rule 10b5-1 trading plan?
The Rule 10b5-1 checkbox is not marked as affirmatively relying on a trading plan. Combined with the absence of any plan-related disclosure in the footnotes, this indicates the holding information is not reported as being under a pre-arranged Rule 10b5-1 plan.
Does this OKUR Form 4/A report any actual buy or sell transactions by Isaac Manke?
No buy or sell transactions are reported. The amendment explains that the previously reported Disposition and Acquisition of an option did not occur. The entry functions as a holding record for the stock option, showing its current terms and remaining underlying shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.
